InsiderClue
Insiders · Profile

Fitzgerald Thomas A

Chief Financial Officer at Transcode Therapeutics. Filing since 16 Jun 2022. CIK 0001854168

Company
Date
Role
Action
Shares
Amount
Of holding
RNAZ Transcode Therapeutics, Inc.
28 Sep 2023
Chief Financial Officer
Bought
49,350
$25.17K
708%
RNAZ Transcode Therapeutics, Inc.
16 Jun 2022
Chief Financial Officer
Bought
12,000
$15.24K
9.4%
2 decisions on file.